- HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia
-
Im M, Kim M, Lee JK, Chang YH, Lee DY, Hong SI, Lee YY, Hong YJ
- KMID: 1096813
- Korean J Lab Med.
- 2010 Feb;30(1):17-19.
- doi: 10.3343/kjlm.2010.30.1.17
Thiazolidinediones (TZD), which are widely used as insulin sensitizers, and fibrates, which are lipid-lowering drugs, are used in the treatment of dyslipidemia that commonly accompanies diabetes. Several reports suggest elevated... -
- CITED
-
- Close
- SHARE
-
- Close
